ANI Pharmaceuticals H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 Baudette, MN HQ🌐 anipharmaceuticals.com
Does ANI Pharmaceuticals sponsor H-1B visas and green cards?
Yes. ANI Pharmaceuticals has filed 49 H-1B LCAs and 2 PERM green-card cases with the U.S. Department of Labor between FY2021 and FY2026. In FY2025–2026 ANI Pharmaceuticals filed 6 H-1B LCAs at a median base salary of $95,000, about 22% below the national H-1B median of $121,966 for the same period, and 2 green-card cases were decided.
Quality Control Analyst roles account for 59% of its H-1B filings.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 2 | $141k |
| FY2025 | 4 | $95k |
| FY2024 | 1 | $66k |
| FY2023 | 2 | $110k |
| FY2022 | 13 | $56k |
| FY2021 | 27 | $60k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Green-card (PERM)
2 green-card (PERM) filings in FY2026, median offer $55k. Too few years to chart a trend.
Worker backgrounds
From green-card (PERM) cases
2 green-card (PERM) cases, all from FY2025. DOL stopped publishing worker details that year.
Patents
- Granted
- 8
- US patents
- Published, not yet granted
- 5
- applications
- Most recent grant
- October 14, 2025
- Top area
- Preparations for medical8
Pay against the local market
ANI Pharmaceuticals’s most-filed occupations and metros, FY2025–FY2026. Its median base salary is 114% of the local BLS median for the same work.
| Occupation | Metro | Filings | ANI Pharmaceuticals pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Financial and Investment Analysts | Trenton, NJ | 1 | $105,000 | $97,920 | 107% |
| Financial Managers | Trenton, NJ | 1 | $210,000 | $175,290 | 120% |
About ANI Pharmaceuticals
- Name (DOL filings)
- ANI Pharmaceuticals
- Listed
- Nasdaq: ANIP
- Incorporated in
- Delaware
- Headquarters
- 104 Carnegie Center Drive Suite 300, Princeton, NJ 08540
- Industry
- Pharma & biotech
- Employees (US, est)
- 725 (2024)
- Revenue FY2025
- $883M +44% from $614M
- Net income FY2025
- $78M +523% from $-19M
- R&D FY2025
- $52M (6% of revenue)
ANI Pharmaceuticals pays a median H-1B base of $60,000 across FY2017–2026, about 45% below the typical Pharma & biotech sponsor.
H-1B sponsors similar to ANI Pharmaceuticals
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Purdue Pharma | 63 | 4 | $183k | 0 | — |
| Spark Therapeutics | 63 | 9 | $103k | 5 | — |
| Servier | 63 | 11 | $181k | 2 | — |
| ANI Pharmaceuticals | 49 | 6 | $95k | 2 | — |
| Adare Pharmaceuticals | 49 | 12 | $100k | 0 | — |
| CelLink | 49 | 24 | $140k | 12 | 38% |
| Aptapharma | 49 | 6 | $76k | 3 | — |
